Efeitos adversos no uso indiscriminado de medicamentos na pandemia da COVID-19: um olhar sobre a cloroquina, hidroxicloroquina e azitromicina

JEB da Costa, OMR Junior, PHF de Almeida… - Research, Society and …, 2022 - rsdjournal.org
Objective: The present study sought to analyze the existing scientific evidence to date on the
adverse effects of the indiscriminate use of chloroquine, hydroxychloroquine and …

[HTML][HTML] Perfil farmacoterapêutico de pacientes internados com COVID-19 em hospital universitário

PB Packeiser, LRL Pereira - Saúde e Pesquisa, 2024 - periodicos.unicesumar.edu.br
Descrever a farmacoterapia no cenário domiciliar e hospitalar e a associação com
características clínico-demográficas de pacientes hospitalizados com COVID-19. Estudo …

Análise de fatores preditivos de morbimortalidade em pacientes acometidos pela Covid-19 internados em uma unidade de terapia intensiva

HG Tótola - 2022 - repositorio.uvv.br
Objetivo: O objetivo do trabalho é analisar os fatores associados a mortalidade em
indivíduos internados acometidos por COVID-19 em Unidade de Terapia Intensiva (UTI) em …

The Economics of COVID-19 Pandemic: Assessing the Macroeconomic Impact

IW Rathnayaka - 2024 - research.usq.edu.au
Severe Acute Respiratory Syndrome (SARS-COV-19) is a viral respiratory disease that
emerged at the end of 2019, leading to devastating economic consequences globally and …

[HTML][HTML] Prehospital period in patients with COVID-19: cardiovascular comorbidity and pharmacotherapy during the first epidemic wave (hospital registry data)

SY Martsevich, MM Lukyanov, MM Pulin… - Rational …, 2022 - rpcardio.elpub.ru
Aim. Based on the data from the register of patients with COVID-19 and community-acquired
pneumonia (CAP), analyze the duration of the prehospital period, cardiovascular …

Parameters linked with Mortality in Egyptian COVID-19 Hospitalized Patients

SN Gaber, AF ELkhateeb, AM Magdy… - Egyptian Journal of …, 2022 - ejmm.journals.ekb.eg
Background: The early prediction of COVID-19 mortality is a key in the patient's treatment.
Objectives: To assess the parameters that are associated with mortality in COVID-19 …

[PDF][PDF] Use of antimicrobials during the COVID-19 pandemic: A qualitative study among stakeholders in Nepal. PLOS Glob Public Health 3 (11): e0002166

B Dhungel, U Thapa Shrestha, S Adhikari, N Adhikari… - 2023 - scienceopen.com
The COVID-19 pandemic was a major public health threat and the pressure to find curative
therapies was tremendous. Particularly in the early critical phase of the pandemic, a lot of …

[PDF][PDF] Проспективный анализ лабораторных параметров крови у пациентов с сердечно-сосудистыми заболеваниями, перенёсших COVID-19 …

ТИ Петелина, НА Мусихина, ВД Гаранина… - Клиническая …, 2022 - infarkta.net
Исследование особенностей и динамики лабораторных биомаркеров у пациентов с
сердечно-сосудистыми заболеваниями (ССЗ), перенесших COVID-19 …

Pharmacotherapeutic profile of patients admitted with COVID-19 at a university hospital.

P Becker Packeiser, LR Leira Pereira - Saúde e Pesquisa, 2024 - search.ebscohost.com
To describe pharmacotherapy in the home and hospital setting and the association with
clinical-demographic characteristics of patients hospitalized with COVID-19. Observational …

Characteristics and outcomes of in-hospital patients with Covid-19 and history of tuberculosis: A matched Case-Control from the Brazilian Covid-19 Registry

RLR de Carvalho Carvalho, DN Pereira, VS Chagas… - 2024 - researchsquare.com
Background: The Covid-19 pandemic caused a negative impact on other infectious diseases
control, prevention, and treatment. Consequently, low and middle-income countries suffer …